Table 1. Clinical characteristics of Lebanese patients with COVID-19 between February and March 2020.
Accession number—GISAID | Sample | Gender | Age (years) | Location of exposure | Sample type | Ct* | Patient status | Signs and symptoms |
---|---|---|---|---|---|---|---|---|
EPI_ISL_450508 | S1 | Male | 56 | Egypt | Sputum/PBS | 14.78 | Hospitalized-deceased | Early stages: flu like symptoms Followed by severe dyspnea and severe ARDS† Chest X-ray: patchy bilateral upper lobe consolidation |
EPI_ISL_450509 | S2 | Male | 63 | Local—community acquired | Nasopharyngeal VTM | 26.15 | Hospitalized-released | Asymptomatic |
EPI_ISL_450510 | S3 | Male | 19 | Iran | Nasopharyngeal VTM | 37.5 | Hospitalized-released | Headache, abdominal pain and diarrhea |
EPI_ISL_450511 | S4 | Female | 33 | United Kingdom | Nasopharyngeal VTM | 34.67 | Hospitalized-released | Rhinorrhea and headache |
EPI_ISL_450512 | S5 | Male | 42 | Iran | Nasopharyngeal VTM | 16.11 | Hospitalized-released | Asymptomatic |
EPI_ISL_450513 | S6 | Male | – | France | Nasopharyngeal VTM | 33.7 | Hospitalized-released | Asymptomatic |
EPI_ISL_454420 | S7 | Female | 41 | Iran | Nasopharyngeal VTM | 20.24 | Hospitalized-released | Sore throat and rhinorrhea |
EPI_ISL_450514 | S8 | Female | 74 | Local—community acquired | Nasopharyngeal VTM | 33.8 | Hospitalized-released | Dyspnea |
EPI_ISL_450515 | S9 | Female | 25 | United Kingdom | Nasopharyngeal VTM | 34 | Hospitalized-released | Asymptomatic |
EPI_ISL_450516 | S10 | Male | 36 | Local—community acquired | Sputum/PBS | – | Hospitalized-released | Asymptomatic |
EPI_ISL_450517 | S11 | Male | 22 | Italy | Nasopharyngeal VTM | – | Hospitalized-released | Early stages: dysuria, fever and flu-like symptoms Followed by severe dyspnea and ARDS Chest CT: bilateral infiltrates with ground glass appearance |
Notes:
CT, RT-PCR Cycle Threshold.
ARDS, acute respiratory distress syndrome.